ICD-10 Coding for Droperidol
There is no specific ICD-10 code for droperidol itself—ICD-10 codes are used to classify diagnoses and medical conditions, not individual medications. However, you would use ICD-10 codes to document the clinical indication for which droperidol is being prescribed or the adverse effects that may result from its use.
Understanding the Distinction
ICD-10 codes classify diseases, symptoms, and clinical conditions rather than medications. When documenting droperidol use in medical records, you need to code:
1. The Clinical Indication (Why the Drug is Given)
Droperidol is a butyrophenone antipsychotic used primarily for:
- Nausea and vomiting: R11.2 (Nausea with vomiting, unspecified) or R11.0 (Nausea alone)
- Agitation/acute behavioral disturbance: R45.1 (Restlessness and agitation) or F19.931 (Other psychoactive substance use, unspecified with withdrawal delirium)
- Delirium management: F05 (Delirium due to known physiological condition) 1
- Procedural sedation: Z51.89 (Encounter for other specified aftercare)
2. Adverse Effects or Complications (If They Occur)
Given droperidol's FDA black box warning for QT prolongation and potential cardiac effects 2, relevant codes include:
- QT prolongation: I45.81 (Long QT syndrome)
- Torsades de pointes: I47.2 (Ventricular tachycardia)
- Extrapyramidal symptoms (acute dystonia, akathisia): G24.01 (Drug-induced subacute dyskinesia) or G21.0 (Malignant neuroleptic syndrome) 2
- Adverse effect of antipsychotic: T43.3X5A (Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter)
3. Drug Poisoning or Overdose
If documenting toxicity or overdose:
- T43.4X1A: Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), initial encounter
- T43.4X5A: Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter 3
Clinical Context
Droperidol is primarily used off-label in emergency departments for agitation and nausea 2. Despite the FDA black box warning issued for QT prolongation and sudden death, multiple studies have shown that droperidol is relatively safe when used appropriately, with serious cardiac events being rare (0.2% in one large retrospective study) 2. The black box warning has significantly reduced its use, though evidence suggests the risk may be overstated 2.
Key Documentation Points
When using droperidol clinically, document:
- The specific indication using appropriate ICD-10 diagnosis codes
- Pre-treatment QT interval if available (especially with IV administration)
- Risk factors for QT prolongation (electrolyte abnormalities, concurrent QT-prolonging medications) 2
- Route of administration (intramuscular preferred over IV in emergency settings) 2
- Any adverse effects using appropriate complication codes
The medication itself (droperidol) would be documented using NDC (National Drug Code) or other pharmaceutical coding systems, not ICD-10.